December 13th, 2010|
Xanodyne Pharmaceuticals, Inc., the maker of the painkiller drugs Darvon® and Darvocet®, has withdrawn these medications from the U.S. market at the request of the FDA.
Darvon and Darvocet contain a chemical known as propoxyphene, which is an opioid used to treat mild to moderate pain. It was first approved by the FDA in 1957 and is sold by prescription under various names alone (e.g., Darvon), or in combination with acetaminophen (e.g., Darvocet).
The FDA has requested that every drug company remove all products containing propoxyphene from the market. According to the FDA, clinical data suggested the drugs put patients at an increased risk for serious or potentially life-threatening heart rhythm abnormalities.
Nurenberg Paris is actively pursuing cases for which test reports and records are available to show a patient was taking the drug within 24 hours of suffering heart failure, heart attack, or sudden cardiac death.
If you or someone you love has taken Darvon or Darvocet and suffered these symptoms, contact us. We want to help.